D-Mannose and cranberry for women have become increasingly popular in supplements focused on urinary and intimate health. Cranberry has been associated with women’s urinary health for generations, while more recently D-mannose, probiotics and the female microbiome have become major areas of scientific interest.
But they don’t all work in the same way — and the research behind them is more interesting than simply labelling them “urinary health ingredients”.
FEM URELA was developed as a multi-ingredient women’s formula bringing several of these areas together.
Each serving provides:
- 900 mg D-mannose
- Cranberry extract equivalent to 2160 mg cranberry
- 2 billion CFU Lactobacillus acidophilus
- Zinc
- Bamboo leaf providing silica
- Ceylon cinnamon
- Oregano leaf
So what does the science actually tell us about these ingredients?
And why are researchers increasingly interested not just in the urinary tract itself, but in the relationship between the urinary microbiome, vaginal microbiome, bacteria and menopause?
Why are urinary tract problems so common in women?
Urinary tract infections — or UTIs — are among the most common bacterial infections experienced by women.
Female anatomy is one reason.
The urethra, which carries urine from the bladder out of the body, is considerably shorter in women than in men. This gives bacteria a much shorter distance to travel to reach the bladder.
The position of the urethral opening in relation to the vaginal and anal areas also means that bacteria originating in the gastrointestinal tract can potentially move into the urinary tract.
The bacterium most frequently associated with uncomplicated UTIs is Escherichia coli (E. coli).
But scientists are now discovering that urinary health is more complicated than the simple presence or absence of one particular bacterium.
The microbial populations living within the vagina and urinary tract may also matter.
This has opened up an entirely new field of research: the female genitourinary microbiome.
What is D-mannose?
D-mannose is a naturally occurring simple sugar.
It is chemically related to glucose and occurs naturally in small quantities in various fruits and plants.
But the body handles D-mannose differently from ordinary glucose.
Following consumption, much of it is absorbed and subsequently excreted through the urinary tract.
This characteristic is one of the reasons researchers became interested in D-mannose in the first place.
And to understand that research, we need to look at something called FimH.
What is FimH?
Some strains of E. coli responsible for urinary infections have microscopic hair-like projections known as type 1 pili.
At the end of these structures sits an adhesion protein called FimH.
Think of FimH as part of the bacterium’s attachment equipment.
FimH can recognise and attach to mannose-containing structures on cells lining the urinary tract.
This ability to adhere to the urinary tract is important because bacteria that cannot remain attached are more readily removed during urination.
Researchers have therefore investigated compounds capable of interacting with this adhesion process.
Where does D-mannose fit in?
FimH has an affinity for mannose.
The proposed mechanism behind D-mannose is therefore not that it acts like an antibiotic or directly “kills” E. coli.
Instead, researchers have investigated whether free D-mannose within the urinary tract can interact with FimH, potentially interfering with the bacterium’s ability to adhere to urinary tract cells.
The FimH-mannose interaction is well established at a biological level and remains an active field of scientific research. [1]
This explains why D-mannose has become so strongly associated with urinary supplements.
However, biological plausibility and clinical effectiveness are not necessarily the same thing.
What does the research say about D-mannose?
D-mannose has attracted considerable scientific interest because of the way it interacts with FimH, an adhesion protein used by certain strains of E. coli to attach to cells lining the urinary tract.
Because FimH has a strong affinity for mannose, researchers have investigated whether D-mannose may help interfere with this attachment process. Rather than acting like an antibiotic or directly killing bacteria, the proposed mechanism is based on reducing bacterial adhesion within the urinary tract.
Clinical studies have explored D-mannose both in women with recurrent UTIs and in those experiencing symptoms of acute cystitis.
Some studies have reported encouraging results. A systematic review examining D-mannose for urinary tract infection and cystitis symptoms found that D-mannose may be useful in improving symptoms, although the evidence was limited by small study sizes and by the fact that several trials used D-mannose alongside other ingredients rather than on its own.
Earlier studies investigating recurrent UTIs also suggested that D-mannose could reduce recurrence, which helped drive much of the interest in the ingredient.
However, more recent and larger placebo-controlled trials have produced less convincing results for preventing recurrent UTIs, and recent meta-analyses have not shown a clear statistically significant reduction in recurrence overall.
The current picture is therefore mixed rather than negative.
The FimH–mannose mechanism is biologically well established, and some clinical studies suggest D-mannose may be useful for urinary symptoms, but the strength of evidence varies depending on whether researchers are looking at acute symptoms or prevention of recurrent infections.
For that reason, D-mannose remains an interesting and widely researched ingredient in urinary health, while further well-designed clinical trials are still needed to determine exactly where it is most effective.
FEM URELA provides 900 mg D-mannose per serving as part of a wider formulation alongside cranberry, Lactobacillus acidophilus, zinc and selected botanicals.
What is cranberry extract?
Cranberries contain a wide variety of naturally occurring plant compounds, including polyphenols.
Among the most interesting are compounds called:
proanthocyanidins — usually abbreviated to PACs.
Cranberries are particularly notable for containing A-type proanthocyanidins.
These molecules have become one of the major areas of cranberry research.
What are cranberry PACs?
Proanthocyanidins belong to the flavonoid family of plant compounds.
Different foods contain different forms.
Cranberries are unusual because they contain significant quantities of A-type PACs, whereas many other fruits predominantly contain B-type PACs.
Researchers have investigated cranberry PACs because of their potential anti-adhesion properties.
Again, the important word here is adhesion.
Certain E. coli bacteria need to attach to the surface of urinary tract cells. Laboratory research suggests cranberry PACs may interfere with some of these bacterial attachment mechanisms.
That gives cranberry and D-mannose an interesting connection.
They are completely different compounds, but scientific interest in both has partly centred around how bacteria interact with the surfaces lining the urinary tract.
What does the latest research say about cranberry?
What does the latest research say about cranberry?
Cranberry is one of the most extensively studied non-antibiotic approaches in women with recurrent urinary tract infections. A major Cochrane review found that cranberry products reduced the risk of symptomatic, culture-confirmed UTIs in several groups, including women with recurrent UTIs.More recent reviews have strengthened interest in the role of proanthocyanidins (PACs) — particularly the amount provided each day. A 2026 review concluded that cranberry products may help reduce recurrence risk in women with recurrent uncomplicated cystitis, with the most consistent results seen in products providing around 36 mg PACs per day or more.
A separate meta-analysis also found that cranberry products providing at least 36 mg PACs daily were associated with a modest reduction in UTI risk.
This suggests that the PAC content and standardisation of a cranberry extract may be more important than the headline cranberry-equivalent dose alone. However, cranberry should not be presented as a treatment for an active UTI, and results still vary according to formulation, population and study design.
Cranberry juice or cranberry extract?
Cranberry juice has a long history of traditional use.
But cranberry juice and cranberry extract aren’t interchangeable.
The composition of commercial drinks varies enormously. Some contain relatively small quantities of cranberry alongside water, other juices and added sugars or sweeteners.
A concentrated extract allows cranberry compounds to be delivered without requiring somebody to drink large volumes of juice.
Where PAC content is standardised, this can provide more useful information about the extract than cranberry-equivalent weight alone.
FEM URELA therefore uses a concentrated cranberry extract equivalent to 2160 mg cranberry per serving.
D-mannose vs cranberry for women: what’s the difference?
D-mannose and cranberry are often grouped together, but they’re very different substances.
D-mannose
D-mannose is a simple sugar.
Scientific interest has particularly focused on the interaction between mannose and the FimH adhesion protein found on certain uropathogenic E. coli.
Cranberry
Cranberry is a fruit containing numerous naturally occurring phytochemicals.
Its A-type proanthocyanidins have attracted particular interest because laboratory research suggests they can influence bacterial adhesion.
So which is better?
There isn’t a simple answer.
The evidence bases are different.
Cranberry currently has stronger clinical evidence for reducing the recurrence of symptomatic UTIs in certain groups of women, while D-mannose is scientifically interesting because the FimH-mannose attachment pathway itself is well characterised.
Rather than treating them as interchangeable, it makes more sense to understand that they represent different areas of urinary-tract research.
Can you take D-mannose and cranberry together?
They are commonly combined in food supplements.
There is no scientific reason to assume that because their research involves bacterial adhesion they are simply duplicates of one another.
Cranberry contains a complex mixture of plant compounds, while D-mannose is an individual sugar with a very specific relationship to mannose-binding structures such as FimH.
FEM URELA combines:
900 mg D-mannose + 2160 mg cranberry equivalent per serving
rather than relying on either ingredient alone.
But FEM URELA doesn’t stop there.
One of the most interesting developments in women’s health science concerns something we didn’t even fully recognise several decades ago:
the urinary microbiome.
Does the bladder have a microbiome?
The traditional medical view was that healthy urine was sterile.
Modern molecular techniques have changed that understanding.
Researchers can now identify communities of microorganisms living within the urinary tract.
These microbial communities are collectively known as the urinary microbiota or urinary microbiome — sometimes called the urobiome.
Compared with the gut, the urinary tract contains relatively low concentrations of microorganisms.
But that doesn’t necessarily mean they’re unimportant.
Research is now examining relationships between urinary microbial communities and factors including:
- age
- menopause
- oestrogen
- vaginal microbiota
- previous UTIs
- recurrent UTIs
- bladder symptoms
The science is still developing, but the urinary tract can no longer simply be viewed as an entirely sterile environment. [5]
Lactobacillus and the female microbiome
One bacterial genus appears repeatedly in research into the female vaginal and urinary microbiomes:
Lactobacillus.
Different Lactobacillus species occur naturally within the vagina and can also be detected within the urinary microbiota.
In many premenopausal women, Lactobacillus species are dominant members of the vaginal microbial community. They produce substances including lactic acid, helping to maintain the characteristically acidic vaginal environment.
This matters because vaginal pH and microbial composition can influence which microorganisms are able to thrive.
However, the female microbiome is complex. It would be too simplistic to describe individual bacteria as universally “good” or “bad”, or to assume that increasing Lactobacillus automatically produces a particular health outcome.
What researchers are increasingly interested in is the relationship between Lactobacillus abundance, vaginal pH, hormones and urinary health.
What happens to Lactobacillus during and after menopause?
This becomes particularly interesting around menopause.
Falling oestrogen levels affect the tissues of the vagina and urinary tract and are commonly associated with changes in the surrounding microbial environment.
Research has repeatedly observed that postmenopausal women tend to have:
- lower abundance of Lactobacillus species
- higher vaginal pH
- greater microbial diversity
- changes in both vaginal and urinary microbial communities
These changes do not mean that every postmenopausal woman will experience urinary or vaginal symptoms, but they help explain why researchers are increasingly studying the genitourinary microbiome alongside hormonal changes.
A 2026 systematic review investigating Lactobacillus-based probiotics specifically in postmenopausal women included nine studies involving 751 participants. Five studies examined urinary outcomes including recurrent cystitis, recurrent UTIs and lower urinary tract symptoms, while four examined vaginal outcomes such as microbiota composition and vaginal pH.
What does the latest research say about probiotics and recurrent UTIs?
There is growing interest in whether probiotic interventions could influence recurrent urinary tract infections, particularly because of the close relationship between the vaginal and urinary microbial environments.
A 2026 systematic review of non-antibiotic approaches to recurrent UTIs in adult women assessed 12 studies, including 10 randomised controlled trials and two observational studies.
The review examined D-mannose, cranberry, probiotics, vaginal oestrogen, methenamine hippurate and immunoprophylaxis.
One of its findings was that probiotic interventions significantly prolonged the time to first UTI recurrence in the studies assessed.
That is an encouraging finding, but it needs to be interpreted carefully.
“Probiotics” are not one single intervention.
The effect of a probiotic can depend on:
- the bacterial species
- the exact strain
- the number of viable organisms supplied
- whether it is taken orally or used intravaginally
- the duration of supplementation
- the age and hormonal status of the women studied
Results from one probiotic preparation therefore cannot automatically be applied to every probiotic supplement.
Oral probiotics versus vaginal Lactobacillus
This distinction is particularly important.
The 2026 systematic review of Lactobacillus-based interventions in postmenopausal women found some encouraging results for intravaginal Lactobacillus, particularly in observational studies of recurrent cystitis.
However, randomised controlled trials produced mixed or negative results compared with antibiotic prophylaxis, and evidence for oral probiotic supplementation was described as particularly limited and heterogeneous.
The authors concluded that Lactobacillus-based interventions may have potential as a complementary approach in selected postmenopausal women, but that better-designed randomised trials are still needed.
So the emerging picture is interesting rather than definitive.
There is enough research to make Lactobacillus an important area of women’s microbiome science, but not enough to say that any oral Lactobacillus supplement will prevent recurrent UTIs.
Why does FEM URELA contain Lactobacillus acidophilus?
FEM URELA provides:
2 billion CFU Lactobacillus acidophilus per serving
Lactobacillus acidophilus is one of the better-known members of the Lactobacillus genus and occurs naturally within parts of the human gastrointestinal and female reproductive environments.
Like other Lactobacillus species, it produces lactic acid during its metabolism.
The inclusion of L. acidophilus in FEM URELA reflects the growing scientific interest in:
- Lactobacillus and the female microbiome
- vaginal microbial ecology
- vaginal pH
- the relationship between the vaginal and urinary environments
- changes in microbial populations across the female lifespan
However, this distinction is important:
Species is not the same as strain
Clinical probiotic research is often strain-specific.
A study showing an effect from one particular strain of Lactobacillus cannot automatically be used as evidence that every strain of the same species will produce the same result.
FEM URELA therefore does not claim that its L. acidophilus prevents or treats a UTI.
Instead, 2 billion CFU L. acidophilus forms one part of a wider women’s formulation alongside D-mannose, cranberry, zinc and selected botanicals.
The vaginal-bladder-gut connection
One of the most interesting developments in current women’s health research is the growing recognition that the vagina, urinary tract and gastrointestinal tract may not function as entirely separate microbial environments.
Researchers increasingly discuss a possible:
vaginal–bladder–gut axis
Many bacteria associated with urinary infection originate in the gastrointestinal tract.
The vaginal environment may then provide an intermediate reservoir from which bacteria can potentially enter the urinary tract.
At the same time, hormones such as oestrogen influence vaginal tissues, pH and microbial composition.
The urinary microbiome itself also appears to change with age and menopause.
This means urinary health may be better understood as part of a wider genitourinary microbial ecosystem, rather than simply as an isolated issue involving the bladder.
Research in this area is still evolving, but it provides an important scientific context for why Lactobacillus has become such a major focus in women’s intimate-health research.
What happens to Lactobacillus during menopause?
This becomes particularly relevant during and after menopause.
Falling oestrogen levels affect vaginal tissues and the surrounding environment.
One frequently observed change is an increase in vaginal pH accompanied by lower abundance of Lactobacillus species.
Changes have also been detected within the urinary microbiome.
A 2023 review found that menopause was associated with greater urinary microbial diversity and a lower proportion of Lactobacillus.
More recent research continues to support an association between menopause, Lactobacillus depletion and changes in the vaginal and urinary microbiomes. [5,6]
A 2026 systematic review examining more than 5,000 participants found that postmenopausal women consistently showed reduced Lactobacillus abundance alongside increased microbial diversity.
However, importantly, simply restoring Lactobacillus did not consistently predict improvement in symptoms. [6]
Again, biology is more complicated than “good bacteria versus bad bacteria”.
What about probiotics?
This is another area where supplement marketing can get ahead of the research.
Probiotic effects are highly specific.
Results can depend on:
- bacterial species
- exact bacterial strain
- dose
- formulation
- route of administration
- the population being studied
Research involving one Lactobacillus strain cannot automatically be applied to every other Lactobacillus product.
A 2026 systematic review of Lactobacillus-based interventions in postmenopausal women found some encouraging observations but described the overall evidence as limited and heterogeneous, particularly for orally consumed probiotic products. [7]
So we don’t describe FEM URELA’s live cultures as a treatment for UTIs or menopausal genitourinary symptoms.
What we can say is that the role of Lactobacillus within the female microbiome is an increasingly important field of research.
Why does FEM URELA contain zinc?
FEM URELA also contains zinc.
This ingredient is different from D-mannose and cranberry for women and the botanical ingredients because zinc has established authorised nutritional health claims. [8]
Zinc contributes to:
- normal fertility and reproduction
- normal function of the immune system
- normal acid-base metabolism
- maintenance of normal skin
- maintenance of normal hair
- maintenance of normal nails
- maintenance of normal bones
FEM URELA uses zinc glycinate, in which zinc is bound to the amino acid glycine.
Why bamboo leaf and silica?
Bamboo is naturally rich in silica, a source of the element silicon.
Silicon is present in connective tissues including bone, cartilage and skin, and has attracted scientific interest because of its possible role in collagen formation, connective-tissue structure and bone mineralisation. Reviews have reported positive associations between dietary silicon intake and measures of bone health, although its precise biological role in humans is still not fully established. PubMed
More recent research continues to investigate silicon as a nutritional factor in bone and connective-tissue biology. A 2024 umbrella review concluded that the evidence is biologically interesting but that the available data are still insufficient to define an effective supplemental dose for skeletal health. PubMed
FEM URELA therefore includes bamboo leaf providing 15 mg silica per serving as part of its wider botanical and mineral complex.
Because there is currently no established UK Nutrient Reference Value for silica, we prefer to describe the research rather than make specific health claims for silica supplementation.
Why Ceylon cinnamon?
Ceylon cinnamon is a traditional botanical containing numerous naturally occurring phytochemicals.
One of the best known is cinnamaldehyde, which contributes to cinnamon’s characteristic aroma.
Cinnamon extracts, essential oils and individual cinnamon compounds have been studied extensively in laboratory research for their interactions with microorganisms and bacterial biofilms.
However, laboratory antimicrobial activity should not be confused with evidence that consuming cinnamon can treat an infection in a human being, nor be seen as a substitute for antibiotics or medical treatment. The two are very different levels of evidence.
Why oregano leaf?
Oregano is another traditional herb with an interesting phytochemical profile.
Among its naturally occurring components are:
- carvacrol
- thymol
These compounds have been extensively investigated in laboratory antimicrobial research.
Studies have included experiments involving E. coli and other microorganisms.
But, once again, evidence that an oregano compound affects microorganisms under laboratory conditions does not demonstrate that an oregano supplement prevents or treats a UTI.
FEM URELA contains oregano leaf as part of its wider botanical complex.
What makes FEM URELA different?
There are plenty of cranberry supplements.
There are also plenty of single-ingredient D-mannose products.
FEM URELA was designed differently.
Rather than simply increasing the quantity of one familiar ingredient, the formulation brings together several distinct nutritional and scientific areas:
D-mannose
900 mg per serving
An individual sugar of particular scientific interest because of the mannose-binding FimH adhesion mechanism.
Cranberry
2160 mg cranberry equivalent per serving
A concentrated botanical extract containing naturally occurring phytochemicals, including compounds from the proanthocyanidin family.
Lactobacillus acidophilus
2 billion CFU per serving
A Lactobacillus species included against the background of growing research into Lactobacillus and the female microbial environment.
Zinc
An essential mineral with authorised health claims including contributions to normal fertility and reproduction, immune function and normal acid-base metabolism, plus the maintenance of normal hair, skin, nails and bones.
Bamboo leaf
Included as a natural source of silica.
Ceylon cinnamon + oregano leaf
Two traditional botanicals containing naturally occurring plant compounds of continuing scientific interest in women’s health.
It is therefore better described as a combined women’s nutritional complex than simply another cranberry supplement.
D-mannose and cranberry for women: frequently asked questions
Is D-mannose the same as cranberry?
No.
D-mannose is an individual naturally occurring sugar.
Cranberry is a fruit containing numerous plant compounds, including proanthocyanidins.
Their chemistry and biological behaviour are completely different.
Does cranberry contain D-mannose?
Cranberries can naturally contain very small quantities of various sugars, but a cranberry supplement should not be considered equivalent to a clinically meaningful dose of isolated D-mannose.
The D-mannose in FEM URELA is included separately.
Can D-mannose and cranberry for women be taken together?
They are commonly combined in food supplements and are present together in FEM URELA.
Their areas of scientific interest overlap in relation to bacterial adhesion, but they are different compounds with different mechanisms and evidence bases.
Is cranberry juice the same as cranberry extract?
No.
Juice products vary greatly in concentration and composition.
A cranberry extract allows cranberry-derived compounds to be supplied in a much smaller quantity of material.
FEM URELA provides cranberry extract equivalent to 2160 mg cranberry per serving.
What are cranberry PACs?
PAC stands for proanthocyanidin.
Cranberries contain unusual A-type proanthocyanidins which have been investigated particularly for their interaction with bacterial adhesion.
What is FimH?
FimH is an adhesion protein found at the tip of structures on certain E. coli bacteria.
It can bind to mannose-containing structures on urinary tract cells.
This interaction explains much of the scientific interest surrounding D-mannose.
Does D-mannose cure a UTI?
No food supplement should be presented as curing a UTI.
Although D-mannose has an interesting biological mechanism, newer randomised evidence has not demonstrated a clear reduction in recurrent UTIs. [2]
Anyone who believes they have a UTI should seek appropriate medical advice rather than relying on a supplement.
Does cranberry treat a UTI?
Current evidence does not establish cranberry as a treatment for an existing UTI.
Research is stronger in relation to recurrence in certain populations than it is for treating an active infection. [3,4]
Are probiotics good for the female microbiome?
Lactobacillus species are an important part of the vaginal microbial communities of many women.
However, probiotic research is strain-specific and results vary depending on the particular organism, dose, route and population studied.
It is therefore too simplistic to say that any probiotic automatically improves the vaginal or urinary microbiome.
Does menopause change the vaginal microbiome?
Yes, research has repeatedly identified changes associated with menopause.
Reduced oestrogen is commonly associated with increased vaginal pH, lower Lactobacillus abundance and greater microbial diversity.
Changes have also been observed in the urinary microbiome. [5,6]
This is one reason the relationship between menopause and genitourinary health has become such an active area of research.
The science is evolving
D-mannose, cranberry and the female microbiome are sometimes discussed online as though the science is settled.
It isn’t.
We now understand far more about bacterial adhesion, FimH, cranberry PACs and the urinary microbiome than we did a generation ago.
But new research also challenges earlier assumptions.
Recent D-mannose trials, for example, have been less encouraging than earlier studies.
Probiotic research continues to show how important species, strain and route of administration can be.
And the discovery of the urinary microbiome has changed the old idea that healthy urine is simply sterile.
That’s exactly why we believe women’s supplements should be science-informed rather than science-exaggerated.
FEM URELA brings together D-mannose, concentrated cranberry, Lactobacillus acidophilus, zinc and selected botanicals in one women’s formula — while recognising that a supplement and a medical treatment are not the same thing.
FEM URELA
900 mg D-Mannose | 2160 mg Cranberry Equivalent | 2 Billion CFU L. acidophilus | Zinc | Bamboo Silica | Ceylon Cinnamon | Oregano Leaf
Explore FEM URELA and discover the complete formula.
Important
FEM URELA is a food supplement and is not intended to diagnose, treat, cure or prevent disease.
Symptoms of a UTI can include pain or burning when urinating, needing to urinate more frequently or urgently, cloudy or bloody urine and lower abdominal discomfort.
Seek medical advice for suspected UTIs, particularly where symptoms are severe, worsening or recurrent, or where there is fever, shivering, pain in the back or side, pregnancy or feeling significantly unwell.
Women’s Supplements
-
Menopause Supplement UK – Women’s Nutritional Support with Vitamins, Fibre & Botanicals
Original price was: £25.00.£19.99Current price is: £19.99. -
Menopause Supplement Bundle 3 for 2 Offer
Original price was: £77.97.£50.00Current price is: £50.00. -
-
-
-
Ashwagandha Supplement plus B Vitamins
Original price was: £25.00.£19.99Current price is: £19.99.
You may also like:
Hormone Imbalance in Women: Causes, Symptoms & How Hormones Work
The 100 Symptoms of Perimenopause: Full List + Early Signs – Pretty Pea
Your Gut Microbiome Is Talking to Your Brain — Are You Listening? – Pretty Pea
D-Mannose and Cranberry for Women: Sources
4. Jepson RG, Mihaljevic L, Craig JC. Cranberries for treating urinary tract infections. Cochrane Database of Systematic Reviews, 2023. The review found insufficient evidence for cranberry as a treatment for an existing UTI.
9. Jugdaohsingh R. Silicon and bone health. J Nutr Health Aging. 2007;11(2):99–110. The review discusses human observational data linking silicon intake with bone mineral density, while also stressing that the exact biological role remains uncertain. PubMed
